Professor Nordeng has joined the Editorial Board of the European Journal of Clinical Pharmacology
Coverage includes therapeutic trials; pharmacokinetics; drug metabolism; adverse drug reactions; drug interactions; all aspects of drug development; prescribing policies; pharmacoepidemiology; and matters relating to the safe use of drugs.
Published May 16, 2014 1:31 PM
- Last modified Nov. 22, 2021 11:59 AM